Share
Stelis Biopharma commences construction
01 Jan 2015
1 Min Read
Editorial Team
STELIS Biopharma commenced the construction of its customised, multi-product, biopharmaceutical manufacturing facility at Nusajaya in Johor. STELIS Biopharma and Bio-XCell had previously announced the signing of a build and lease agreement with Bio-XCell for the construction of the building and part of the equipment of the company´s 140,000 sq ft facility, for a total investment amount of $60 mn. The facility will incorporate ´next-gen´ single-use bio-processing technology with both mammalian and microbial manufacturing suites.
Contact: Stelis Biopharma.
Tel: 080-2780 5529. Fax: 080-6784 0800.
Contact: Stelis Biopharma.
Tel: 080-2780 5529. Fax: 080-6784 0800.
STELIS Biopharma commenced the construction of its customised, multi-product, biopharmaceutical manufacturing facility at Nusajaya in Johor. STELIS Biopharma and Bio-XCell had previously announced the signing of a build and lease agreement with Bio-XCell for the construction of the building and part of the equipment of the company´s 140,000 sq ft facility, for a total investment amount of $60 mn. The facility will incorporate ´next-gen´ single-use bio-processing technology with both mammalian and microbial manufacturing suites. Contact: Stelis Biopharma. Tel: 080-2780 5529. Fax: 080-6784 0800.
Related Stories
Gold Stories
Opinion Poll
Question : Which technological advancement do you believe will most transform the real estate industry in the coming years?
Live Results :
Virtual Reality and 3D Property Tours
Smart Home and Building Automation
Blockchain for Property Transactions
Big Data and Predictive Analytics for Market Insights
Augmented Reality for Property Staging and Design
Drone Technology for Aerial Photography and Site Analysis
Latest updates
26 Apr 2024
26 Apr 2024